These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 19190113

  • 1. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.
    Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM.
    J Clin Endocrinol Metab; 2009 May; 94(5):1623-9. PubMed ID: 19190113
    [Abstract] [Full Text] [Related]

  • 2. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ, van Loon HC, van der Klauw MM, Elderson MF, Slagter SN, Kobold AM, Kema IP, Links TP, van Vliet-Ostaptchouk JV, Wolffenbuttel BH.
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [Abstract] [Full Text] [Related]

  • 3. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial.
    Saravanan P, Simmons DJ, Greenwood R, Peters TJ, Dayan CM.
    J Clin Endocrinol Metab; 2005 Feb; 90(2):805-12. PubMed ID: 15585551
    [Abstract] [Full Text] [Related]

  • 4. Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement.
    Saravanan P, Visser TJ, Dayan CM.
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3389-93. PubMed ID: 16804044
    [Abstract] [Full Text] [Related]

  • 5. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
    Castagna MG, Dentice M, Cantara S, Ambrosio R, Maino F, Porcelli T, Marzocchi C, Garbi C, Pacini F, Salvatore D.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1623-1630. PubMed ID: 28324063
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy.
    Appelhof BC, Peeters RP, Wiersinga WM, Visser TJ, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ, Fliers E.
    J Clin Endocrinol Metab; 2005 Nov 01; 90(11):6296-9. PubMed ID: 16144953
    [Abstract] [Full Text] [Related]

  • 7. Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?
    Wiersinga WM.
    Eur J Endocrinol; 2009 Dec 01; 161(6):955-9. PubMed ID: 19808902
    [Abstract] [Full Text] [Related]

  • 8. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.
    Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ.
    N Engl J Med; 1999 Feb 11; 340(6):424-9. PubMed ID: 9971866
    [Abstract] [Full Text] [Related]

  • 9. Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
    Arici M, Oztas E, Yanar F, Aksakal N, Ozcinar B, Ozhan G.
    Endocr J; 2018 Mar 28; 65(3):317-323. PubMed ID: 29321381
    [Abstract] [Full Text] [Related]

  • 10. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun 28; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

  • 11. The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine.
    Al-azzam SI, Alkhateeb AM, Al-Azzeh O, Alzoubi KH, Khabour OF.
    Exp Clin Endocrinol Diabetes; 2013 May 28; 121(5):300-5. PubMed ID: 23329579
    [Abstract] [Full Text] [Related]

  • 12. A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine.
    Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferrucci L, Melzer D, Saravanan P, Visser TJ, Ceresini G, Hattersley AT, Vaidya B, Dayan CM, Frayling TM.
    J Clin Endocrinol Metab; 2008 Aug 28; 93(8):3075-81. PubMed ID: 18492748
    [Abstract] [Full Text] [Related]

  • 13. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.
    Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J.
    Ann Intern Med; 2005 Mar 15; 142(6):412-24. PubMed ID: 15767619
    [Abstract] [Full Text] [Related]

  • 14. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC, Kim BS.
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct 15; 25(5):341-346. PubMed ID: 30063552
    [Abstract] [Full Text] [Related]

  • 15. Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment.
    Luo M, Zhou XH, Zou T, Keyim K, Dong LM.
    Genet Mol Res; 2015 May 22; 14(2):5407-16. PubMed ID: 26125736
    [Abstract] [Full Text] [Related]

  • 16. The relationship of 19 functional polymorphisms in iodothyronine deiodinase and psychological well-being in hypothyroid patients.
    Young Cho Y, Jeong Kim H, Won Jang H, Hyuk Kim T, Ki CS, Wook Kim S, Hoon Chung J.
    Endocrine; 2017 Jul 22; 57(1):115-124. PubMed ID: 28466400
    [Abstract] [Full Text] [Related]

  • 17. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.
    de Jong FJ, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ, Breteler MM.
    J Clin Endocrinol Metab; 2007 Feb 22; 92(2):636-40. PubMed ID: 17105838
    [Abstract] [Full Text] [Related]

  • 18. The effect of the D1-C785T polymorphism in the type 1 iodothyronine deiodinase gene on the circulating thyroid hormone levels in Romanian women with preeclampsia. Association with the degree of severity and pregnancy outcome of preeclampsia.
    Procopciuc LM, Hazi GM, Caracostea G, Nemeti G, Olteanu I, Dragatoiu GH, Stamatian F.
    Gynecol Endocrinol; 2012 May 22; 28(5):386-90. PubMed ID: 22339181
    [Abstract] [Full Text] [Related]

  • 19. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial.
    Pollock MA, Sturrock A, Marshall K, Davidson KM, Kelly CJ, McMahon AD, McLaren EH.
    BMJ; 2001 Oct 20; 323(7318):891-5. PubMed ID: 11668132
    [Abstract] [Full Text] [Related]

  • 20. Effect of DIO2 Gene Polymorphism on Thyroid Hormone Levels and Its Correlation with the Severity of Schizophrenia in a Pakistani Population.
    Hanif F, Amir Q, Washdev W.
    Int J Mol Sci; 2024 Feb 05; 25(3):. PubMed ID: 38339190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.